Comparison between Mahamaya Lifesciences IPO and Western Overseas Study Abroad IPO.
Mahamaya Lifesciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Western Overseas Study Abroad IPO is a SME Fixed Price proposed to list at BSE SME.
| Mahamaya Lifesciences IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | Sobhagya Capital Options Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Mahamaya Lifesciences IPO is up to ₹0.00 Cr whereas the issue size of the Western Overseas Study Abroad IPO is up to ₹0.00 Cr. The final issue price of Mahamaya Lifesciences IPO is and of Western Overseas Study Abroad IPO is .
| Mahamaya Lifesciences IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 56,38,800 shares | 18,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 5,40,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 61,78,800 shares | 18,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Mahamaya Lifesciences IPO opens on , while Western Overseas Study Abroad IPO opens on . The closing date of Mahamaya Lifesciences IPO and Western Overseas Study Abroad IPO is , and , respectively.
| Mahamaya Lifesciences IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Mahamaya Lifesciences IPO P/E ratio is , as compared to Western Overseas Study Abroad IPO P/E ratio of .
| Mahamaya Lifesciences IPO | Western Overseas Study Abroad IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Mahamaya Lifesciences Limited Financial Information (Restated Consolidated)
| Western Overseas Study Abroad Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 77.27 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.67% | 31.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 32.38% | 33.39% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.16% | 27.29% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mahamaya Lifesciences IPO Retail Individual Investors (RII) are offered while in Western Overseas Study Abroad IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Mahamaya Lifesciences IPO and in Western Overseas Study Abroad IPO.
| Mahamaya Lifesciences IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Mahamaya Lifesciences IPO subscribed in total, whereas Western Overseas Study Abroad IPO subscribed .
| Mahamaya Lifesciences IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
